Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells

International Journal of Cancer

Volumn 133, Issue 2, 2013, Pages 416-426

  Wang, Haobin ^a   Rana, Sanyukta ^a   Giese, Nathalia ^a   Büchler, Markus W ^a   Zöller, Margot ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cancer initiating cells; CD44 variant isoforms; holoclones; pancreatic cancer; spheroid growth; tetraspanins

Indexed keywords

ALPHA6BETA4 INTEGRIN; CD44V6 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; TETRASPANIN; TETRASPANIN 8; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; CELL EXPANSION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM SURVIVAL; METASTASIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; UPREGULATION;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA6BETA4; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; TETRASPANINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877817373     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28044     Document Type: Article

References (52)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Wang Z, Li Y, Ahmad A, et al. Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol 2011; 8: 27-33.
3. Quante M, Wang TC,. Stem cells in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2009; 6: 724-37.
4. Lonardo E, Hermann PC, Heeschen C,. Pancreatic cancer stem cells-update and future perspectives. Mol Oncol 2010; 4: 431-42.
5. Simeone DM,. Pancreatic cancer stem cells. implications for the treatment of pancreatic cancer. Clin Cancer Res 2008; 14: 5646-8.
6. Cho RW, Clarke MF,. Recent advances in cancer stem cells. Curr Opin Genet Dev 2008; 18: 48-53.
7. Ding XW, Wu JH, Jiang CP,. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci 2010; 86: 631-7.
8. Takaishi S, Okumura T, Wang TC,. Gastric cancer stem cells. J Clin Oncol 2008; 26: 2876-82.
9. Vollmers A, Wallace L, Fullard N, et al. Two- and three-dimensional culture of keratinocyte stem and precursor cells derived from primary murine epidermal cultures. Stem Cell Rev 2012; 8: 402-13.
10. Li H, Chen X, Calhoun-Davis T, et al. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 2008; 68: 1820-5.
11. Tan L, Sui X, Deng H, et al. Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells. PLoS One 2011; 6: e23383.
12. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-7.
13. Li C, Wu JJ, Hynes M, et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterol 2011; 141: 2218-27.
14. Zöller M,. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 2011; 11: 254-67.
15. Gaviraghi M, Tunici P, Valensin S, et al. Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Biosci Rep 2010; 31: 45-55.
16. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-23.
17. Jimeno A, Feldmann G, Suárez-Gauthier A, et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 2009; 8: 310-4.
18. Mathivanan S, Ji H, Simpson RJ,. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 1907-20.
19. Zöller M,. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9: 40-55.
20. Gesierich S, Paret C, Hildebrand D, et al. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 2005; 11: 2840-52-.
21. Puglisi MA, Giuliani L, Fierabracci A,. Identification and characterization of a novel expandable adult stem/progenitor cell population in the human exocrine pancreas. J Endocrinol Invest 2008; 31: 563-72.
22. Papini S, Cecchetti D, Campani D, et al. Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture. Stem Cells 2003; 21: 481-94.
23. Sergeant G, Vankelecom H, Gremeaux L, et al. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat Rev Clin Oncol 2009; 6: 580-6.
24. Mimeault M, Batra SK,. New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence. Histol Histopathol 2010; 25: 1057-73.
25. Malik FA, Sanders AJ, Jiang WG,. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis. Histol Histopathol 2009; 24: 519-30.
26. Conley BJ, Young JC, Trounson AO, et al. Derivation, propagation and differentiation of human embryonic stem cells. Int J Biochem Cell Biol 2004; 36: 555-67.
27. Hendrix A, Westbroek W, Bracke M, et al. An ex(o)citing machinery for invasive tumor growth. Cancer Res 2010; 70: 9533-7.
28. Jung T, Gross W, Zöller M,. CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance. J Biol Chem 2011; 286: 15862-74.
29. Peinado H, Alečkovic̈ M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883-91.
30. Sipos B, Möser S, Kalthoff H, et al. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003; 442: 444-52.
31. Suemizu H, Monnai M, Ohnishi Y, et al. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. Int J Oncol 2007; 31: 741-51.
32. Kim MP, Fleming JB, Wang H, et al. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One 2011; 6: e20636.
33. Beaver CM,. The effect of culture conditions on colony morphology and proliferative capacity in human prostate cancer cell lines. Cell Biol Toxicol 2012; 28: 291-301.
34. Monteiro J, Fodde R,. Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur J Cancer 2010; 46: 1198-1203.
35. Matsuzaki H, Schmied BM, Ulrich A, et al. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells. Clin Cancer Res 2001; 7: 407-14.
36. Du Z, Qin R, Wei C, et al. Pancreatic cancer cells resistant to chemoradiotherapy rich in «stem-cell-like» tumor cells. Dig Dis Sci 2011; 56: 741-50.
37. Magnon C, Lucas D, Frenette PS,. Trafficking of stem cells. Methods Mol Biol 2011; 750: 3-24.
38. Liu S, Clouthier SG, Wicha MS,. Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia 2012; 17: 15-21.
39. Mueller MT, Hermann PC, Heeschen C,. Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Front Biosci 2010; 2: 602-13.
40. Tsuji T, Ibaragi S, Shima K, et al. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res 2008; 68: 10377-86.
41. Gherardi E, Birchmeier W, Birchmeier C, et al. Targeting MET in cancer: rationale and progress. Nat Rev Cancer 2012; 12: 89-103.
42. Kusuma N, Denoyer D, Eble JA, et al. Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis. Int J Cancer 2012; 130: 555-66.
43. Klingbeil P, Marhaba R, Jung T, et al. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Mol Cancer Res 2009; 7: 168-79.
44. Cruz-Monserrate Z, Qiu S, Evers BM, et al. Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod Pathol 2007; 20: 656-67.
45. Zlotnik A,. New insights on the role of CXCR4 in cancer metastasis. J Pathol 2008; 215: 211-3.
46. Greco C, Bralet MP, Ailane N, et al. E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma. Cancer Res 2010; 70: 7674-83.
47. Berthier-Vergnes O, Kharbili ME, de la Fouchardière A, et al. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion. Br J Cancer 2011; 104: 155-65.
48. Guo Q, Xia B, Zhang F, et al. Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions. PLoS One 2012; 7: e38464.
49. Friess H, Guo XZ, Berberat P, et al. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases. Int J Cancer 1998; 79: 349-55.
50. Zhu GH, Huang C, Qiu ZJ, et al. Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci 2011; 56: 1090-8.
51. Doherty RE, Haywood-Small SL, Sisley K, et al. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells. Biochem Biophys Res Commun 2011; 414: 801-7.
52. Rasheed ZA, Yang J, Wang Q, et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst 2010; 102: 340-51.